See up to 3 months of VCYT. The 7-day demo opens the 1M and 3M ranges and puts VCYT on your watchlist.
Start 7-day demoLatest VCYT insider trades
John Leite - OfficerOpen-market sale$161K- Jens Holstein - DirectorOpen-market sale$205K
About VERACYTE, INC. (VCYT)
VERACYTE, INC. files with the SEC under CIK 0001384101 and is classified as medical laboratories. We track it alongside the rest of the Health Care sector.
VCYT Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 9 | 30,895 | $1.31M |
| Tax withholding / forfeiture | 6 | 24,561 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
VCYT insider transactions (Form 4)
4991 Form 4 filings on record, the earliest from Nov 14, 2024, newest first. Filing history page 1 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| John Leite - Officer | Open-market sale | Common Stock | 4,015 | $40.00 | $161K | |
| Jens Holstein - Director | Open-market sale | Common Stock | 5,000 | $40.95 footnote F2 | $205K | |
| ||||||
 Jonathan Wygant - Officer | Tax withholding / forfeiture | Common Stock | 1,361 | $44.88 | $61K | |
| John Leite - Officer | Tax withholding / forfeiture | Common Stock | 3,961 | $44.88 | $178K | |
 Phillip G. Febbo - Officer | Tax withholding / forfeiture | Common Stock | 3,639 | $44.88 | $163K | |
| Phillip G. Febbo - Officer | Open-market sale | Common Stock | 10,405 | $42.89 footnote F3 | $446K | |
| Phillip G. Febbo - Officer | Open-market sale | Common Stock | 2,705 | $43.66 footnote F4 | $118K | |
| ||||||
 Rebecca Chambers - Officer | Tax withholding / forfeiture | Common Stock | 3,603 | $44.88 | $162K | |
| Rebecca Chambers - Officer | Open-market sale | Common Stock | 2,477 | $42.81 footnote F3 | $106K | |
| Rebecca Chambers - Officer | Open-market sale | Common Stock | 1,175 | $43.71 footnote F4 | $51K | |
| ||||||
 Annie McGuire - Officer | Tax withholding / forfeiture | Common Stock | 3,215 | $44.88 | $144K | |
| Annie McGuire - Officer | Open-market sale | Common Stock | 2,154 | $42.79 footnote F4 | $92K | |
| Annie McGuire - Officer | Open-market sale | Common Stock | 1,100 | $43.67 footnote F5 | $48K | |
| ||||||
| Marc Stapley - Officer | Tax withholding / forfeiture | Common Stock | 8,782 | $44.88 | $394K | |
 Muna Bhanji - Director | Open-market sale | Common Stock | 1,864 | $42.97 | $80K | |
| Karin Eastham - Director | Open-market sale | Common Stock | 3,200 | $52.78 footnote F2 | $169K | |
| Karin Eastham - Director | Open-market sale | Common Stock | 529 | $53.55 footnote F3 | $28K | |
| ||||||
| Karin Eastham - Director | Grant or award | Common Stock | 5,272 | $0.00 | - | |
| Evan/ Fa Jones - Director | Grant or award | Common Stock | 5,272 | $0.00 | - | |
 David Brent Shafer - Director | Grant or award | Common Stock | 5,272 footnote F1 | $0.00 | - | |
| ||||||
 Eliav Barr - Director | Grant or award | Common Stock | 5,272 | $0.00 | - | |
 Robert S. Epstein - Director | Grant or award | Common Stock | 5,272 | $0.00 | - | |
| Jens Holstein - Director | Grant or award | Common Stock | 5,272 | $0.00 | - | |
| Muna Bhanji - Director | Grant or award | Common Stock | 5,272 | $0.00 | - | |
| Thomas F. Miller - Director | Grant or award | Common Stock | 5,272 | $0.00 | - | |
| Annie McGuire - Officer | Tax withholding / forfeiture | Common Stock | 3,292 | $47.80 | $157K | |
| Annie McGuire - Officer | Open-market sale | Common Stock | 1,400 | $49.31 footnote F3 | $69K | |
| Annie McGuire - Officer | Open-market sale | Common Stock | 1,776 | $50.12 footnote F4 | $89K | |
| ||||||
| Jonathan Wygant - Officer | Tax withholding / forfeiture | Common Stock | 1,361 | $47.80 | $65K | |
| Rebecca Chambers - Officer | Tax withholding / forfeiture | Common Stock | 3,693 | $47.80 | $177K | |
| Rebecca Chambers - Officer | Open-market sale | Common Stock | 1,600 | $49.28 footnote F3 | $79K | |
| Rebecca Chambers - Officer | Open-market sale | Common Stock | 1,961 | $50.09 footnote F4 | $98K | |
| ||||||
| Phillip G. Febbo - Officer | Tax withholding / forfeiture | Common Stock | 3,730 | $47.80 | $178K | |
| Marc Stapley - Officer | Tax withholding / forfeiture | Common Stock | 9,012 | $47.80 | $431K | |
| Marc Stapley - Officer | Option exercise | Common Stock | 138,051 | $36.60 | $5.05M | |
| Marc Stapley - Officer | Open-market sale | Common Stock | 138,051 | $50.12 footnote F4 | $6.92M | |
| Marc Stapley - Officer | Option exercise | Stock Option (right to buy) | 138,051 | $0.00 | - | |
| ||||||
| John Leite - Officer | Tax withholding / forfeiture | Common Stock | 4,059 | $47.80 | $194K | |
| John Leite - Officer | Open-market sale | Common Stock | 13,975 | $50.07 footnote F3 | $700K | |
| ||||||
| Jonathan Wygant - Officer | Option exercise | Common Stock | 24,000 | $24.80 | $595K | |
| Jonathan Wygant - Officer | Open-market sale | Common Stock | 24,000 | $45.40 footnote F1 | $1.09M | |
| Jonathan Wygant - Officer | Option exercise | Stock Option (right to buy) | 24,000 | $0.00 | - | |
| ||||||
| Robert S. Epstein - Director | Open-market sale | Common Stock | 10,000 | $44.01 footnote F2 | $440K | |
| ||||||
| Annie McGuire - Officer | Open-market sale | Common Stock | 5,102 | $38.05 | $194K | |
| Annie McGuire - Officer | Open-market sale | Common Stock | 5,102 | $40.00 | $204K | |
| Kevin Richard Haas - Officer | Grant or award | Common Stock | 44,221 | $0.00 | - | |
| Jonathan Wygant - Officer | Grant or award | Common Stock | 10,525 | $0.00 | - | |
| Annie McGuire - Officer | Grant or award | Common Stock | 32,892 | $0.00 | - | |
| Annie McGuire - Officer | Grant or award | Common Stock | 26,314 | $0.00 | - | |
Item 1.01, 2.01, 7.01, 9.01
Item 2.02, 9.01
Item 5.02, 5.07
Item 2.02, 9.01
Recent VCYT Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JENS HOLSTEIN | Director | 7,500 | $353K | View on EDGAR | |
| JOHN LEITE | Officer | 4,015 | $160K |
Stock trades in VCYT disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Gilbert Ray Cisneros, Jr.Democrat, CA-31 | Purchase |
VCYT insider trading FAQ
What is the latest insider trade for VCYT?
VERACYTE, INC. (VCYT) had 9 insider filings in the last 90 days, with the most recent on 2026-09-22. The full record for VCYT runs to 91 Form 4 filings, the earliest from 2024-11-14. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying VCYT stock?
No insider purchases of VCYT were filed in the last 90 days.
How many insiders are selling VCYT stock?
9 insider sales of VCYT were filed in the last 90 days, totaling $1.31M.
Where can I see VCYT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects VCYT Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John Leite view on EDGAR
- - Jens Holstein view on EDGAR
- - Jonathan Wygant view on EDGAR
- - John Leite view on EDGAR
- - Phillip G. Febbo view on EDGAR
- - Rebecca Chambers view on EDGAR
- - Annie McGuire view on EDGAR
- - Marc Stapley view on EDGAR
- - Muna Bhanji view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where VCYT's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow VCYT with a 7-day demo
- VCYT on your watchlist
- Every VCYT Form 4 filing on record
- Up to 3 months of VCYT price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
